Purpose: We investigate the vaporization of phase-change ultrasound contrast agents using photon radiation for dosimetry perspectives in radiotherapy. Methods: We studied superheated perfluorobutane nanodroplets with a crosslinked poly(vinylalcohol) shell. The nanodroplets' physico-chemical properties, and their acoustic transition have been assessed firstly. Then, poly(vinylalcohol)-perfluorobutane nanodroplets were dispersed in poly(acrylamide) hydrogel phantoms and exposed to a photon beam. We addressed the effect of several parameters influencing the nanodroplets radiation sensitivity (energy/delivered dose/dose rate/temperature). The nanodroplets-vaporization post-photon exposure was evaluated using ultrasound imaging at a low mechanic...
Recent efforts using perfluorocarbon (PFC) nanoparticles in conjunction with acoustic droplet vapori...
Ultrasonically activated phase-change contrast agents (PCCAs) based on perfluorocarbon droplets have...
Methods allowing for in situ dosimetry and range verification are essential in radiotherapy to reduc...
We investigate the vaporization of phase-change ultrasound contrast agents using photon radiation fo...
Purpose: Despite the physical benefits of protons over conventional photon radiation in cancer treat...
Technologies enabling in vivo range verification during proton therapy are actively sought as a mean...
Diagnostic ultrasound is a safe, inexpensive and highly portable real-time imaging modality for view...
Technologies enabling in vivo range verification during proton therapy are actively sought as a mean...
Phase change contrast agents for ultrasound (US) imaging consist of nanodroplets (NDs) with a perflu...
Laser-activated perfluorocarbon nanodroplets (PFCnDs) are emerging phase-change contrast agents that...
Phase change contrast agents for ultrasound (US) imaging consist of nanodroplets (NDs) with a perflu...
A combination of ultrahigh-speed optical imaging (5 × 106 frames/s), B-mode ultrasound and passive c...
Recent efforts using perfluorocarbon (PFC) nanoparticles in conjunction with acoustic droplet vapori...
Ultrasonically activated phase-change contrast agents (PCCAs) based on perfluorocarbon droplets have...
Methods allowing for in situ dosimetry and range verification are essential in radiotherapy to reduc...
We investigate the vaporization of phase-change ultrasound contrast agents using photon radiation fo...
Purpose: Despite the physical benefits of protons over conventional photon radiation in cancer treat...
Technologies enabling in vivo range verification during proton therapy are actively sought as a mean...
Diagnostic ultrasound is a safe, inexpensive and highly portable real-time imaging modality for view...
Technologies enabling in vivo range verification during proton therapy are actively sought as a mean...
Phase change contrast agents for ultrasound (US) imaging consist of nanodroplets (NDs) with a perflu...
Laser-activated perfluorocarbon nanodroplets (PFCnDs) are emerging phase-change contrast agents that...
Phase change contrast agents for ultrasound (US) imaging consist of nanodroplets (NDs) with a perflu...
A combination of ultrahigh-speed optical imaging (5 × 106 frames/s), B-mode ultrasound and passive c...
Recent efforts using perfluorocarbon (PFC) nanoparticles in conjunction with acoustic droplet vapori...
Ultrasonically activated phase-change contrast agents (PCCAs) based on perfluorocarbon droplets have...
Methods allowing for in situ dosimetry and range verification are essential in radiotherapy to reduc...